Omega Therapeutics Inc
NASDAQ:OMGA 4:00:00 PM EDT
| Market Cap (Intraday) | 99.25M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.85 |
| 50-Day MA | $1.92 |
| 200-Day MA | $5.15 |
Omega Therapeutics Inc Stock, NASDAQ:OMGA
140 First Street, Suite 501, Cambridge, Massachusetts 02141
United States of America
Phone: +1.617.949.4360
Number of Employees: 117
Description
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.